SIMILAR PATTERNS OF AMINO ACIDS FOR 5BXN_H_BO2H301_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1c4k PROTEIN (ORNITHINE
DECARBOXYLASE)

(Lactobacillus
sp. 30A) 		PF01276
(OKR_DC_1)
PF03709
(OKR_DC_1_N)
PF03711
(OKR_DC_1_C) 		5 THR A 243
GLN A 612
GLY A 252
THR A 291
ASP A 535
 None
 1.09A 5bxnH-1c4kA:
undetectable
5bxnI-1c4kA:
undetectable		 5bxnH-1c4kA:
17.43
5bxnI-1c4kA:
15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f80 HOLO-(ACYL CARRIER
PROTEIN) SYNTHASE

(Bacillus
subtilis) 		PF01648
(ACPS) 		5 THR A  10
GLN A 113
ALA A  51
GLY A  52
ALA A  56
 None
 1.20A 5bxnH-1f80A:
undetectable
5bxnI-1f80A:
undetectable		 5bxnH-1f80A:
20.26
5bxnI-1f80A:
22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fts FTSY

(Escherichia
coli) 		PF00448
(SRP54)
PF02881
(SRP54_N) 		5 GLN A 234
GLY A 454
THR A 206
ALA A 452
THR A 451
 None
 1.23A 5bxnH-1ftsA:
undetectable
5bxnI-1ftsA:
undetectable		 5bxnH-1ftsA:
24.82
5bxnI-1ftsA:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i9r IMMUNOGLOBULIN H

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
 None
 0.85A 5bxnH-1i9rH:
undetectable
5bxnI-1i9rH:
undetectable		 5bxnH-1i9rH:
21.32
5bxnI-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nbw GLYCEROL DEHYDRATASE
REACTIVASE BETA
SUBUNIT

(Klebsiella
pneumoniae) 		PF02288
(Dehydratase_MU) 		5 SER B  58
GLN B  37
ALA B  52
GLY B  51
THR B  75
 None
 1.22A 5bxnH-1nbwB:
undetectable
5bxnI-1nbwB:
undetectable		 5bxnH-1nbwB:
21.08
5bxnI-1nbwB:
18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o5w AMINE OXIDASE
[FLAVIN-CONTAINING]
A

(Rattus
norvegicus) 		PF01593
(Amino_oxidase) 		5 ALA A 433
GLY A 434
THR A 435
ALA A 438
THR A 437
 None
FAD  A 652 (-3.4A)
FAD  A 652 (-3.6A)
None
None
 0.98A 5bxnH-1o5wA:
undetectable
5bxnI-1o5wA:
undetectable		 5bxnH-1o5wA:
18.82
5bxnI-1o5wA:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o9b HYPOTHETICAL
SHIKIMATE
5-DEHYDROGENASE-LIKE
PROTEIN YDIB

(Escherichia
coli) 		PF08501
(Shikimate_dh_N) 		5 THR A  93
GLN A  72
GLY A 103
ALA A  85
THR A  82
 None
PO4  A 303 (-3.6A)
None
None
None
 1.19A 5bxnH-1o9bA:
undetectable
5bxnI-1o9bA:
undetectable		 5bxnH-1o9bA:
22.60
5bxnI-1o9bA:
22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oh2 SUCROSE SPECIFIC
PORIN

(Salmonella
enterica) 		PF02264
(LamB) 		6 THR Q 376
GLN Q 373
ALA Q 107
GLY Q 106
ALA Q 101
THR Q  99
 None
 1.48A 5bxnH-1oh2Q:
undetectable
5bxnI-1oh2Q:
undetectable		 5bxnH-1oh2Q:
20.67
5bxnI-1oh2Q:
18.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q5q PROTEASOME BETA-TYPE
SUBUNIT 1

(Rhodococcus
erythropolis) 		PF00227
(Proteasome) 		7 THR H   1
GLN H  22
LYS H  33
ALA H  46
GLY H  47
THR H  48
ALA H  49
 None
 0.67A 5bxnH-1q5qH:
26.0
5bxnI-1q5qH:
24.6		 5bxnH-1q5qH:
26.21
5bxnI-1q5qH:
26.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rzf FAB E51 HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.96A 5bxnH-1rzfH:
undetectable
5bxnI-1rzfH:
undetectable		 5bxnH-1rzfH:
19.46
5bxnI-1rzfH:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rzg FAB 412D LIGHT CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER A 188
GLY A 134
THR A 135
ALA A 136
THR A 131
 None
 0.96A 5bxnH-1rzgA:
undetectable
5bxnI-1rzgA:
undetectable		 5bxnH-1rzgA:
21.69
5bxnI-1rzgA:
23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1um4 ANTIBODY 21H3 H
CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 194
GLY H 140
THR H 141
ALA H 142
THR H 137
 None
 0.85A 5bxnH-1um4H:
undetectable
5bxnI-1um4H:
undetectable		 5bxnH-1um4H:
20.75
5bxnI-1um4H:
24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uwe ANTIBODY 14D9

(Homo sapiens;
Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 5bxnH-1uweH:
undetectable
5bxnI-1uweH:
undetectable		 5bxnH-1uweH:
22.48
5bxnI-1uweH:
23.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uxz CELLULASE B

(Cellvibrio
mixtus) 		PF03422
(CBM_6) 		5 GLY A  91
THR A  94
ALA A  62
THR A  89
ASP A  24
 None
 1.21A 5bxnH-1uxzA:
undetectable
5bxnI-1uxzA:
undetectable		 5bxnH-1uxzA:
18.57
5bxnI-1uxzA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v8d HYPOTHETICAL PROTEIN
(TT1679)

(Thermus
thermophilus) 		PF04260
(DUF436) 		5 THR A  72
ALA A 145
GLY A 144
ALA A 147
THR A 148
 None
 1.23A 5bxnH-1v8dA:
undetectable
5bxnI-1v8dA:
undetectable		 5bxnH-1v8dA:
20.97
5bxnI-1v8dA:
23.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a0u INITIATION FACTOR 2B

(Leishmania
major) 		PF01008
(IF-2B) 		5 ALA A 189
GLY A 188
THR A 187
ALA A 191
THR A 192
 None
 1.19A 5bxnH-2a0uA:
undetectable
5bxnI-2a0uA:
undetectable		 5bxnH-2a0uA:
21.79
5bxnI-2a0uA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b4c ANTI-HIV-1 GP120
IMMUNOGLOBULIN X5
HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.92A 5bxnH-2b4cH:
undetectable
5bxnI-2b4cH:
undetectable		 5bxnH-2b4cH:
20.72
5bxnI-2b4cH:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eh7 HUMANIZED KR127 FAB,
HEAVY CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.93A 5bxnH-2eh7H:
undetectable
5bxnI-2eh7H:
undetectable		 5bxnH-2eh7H:
21.43
5bxnI-2eh7H:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fhg PROTEASOME, BETA
SUBUNIT

(Mycobacterium
tuberculosis) 		no annotation 5 THR H 301
LYS H 333
ALA H 346
GLY H 347
ALA H 352
 None
 1.13A 5bxnH-2fhgH:
25.2
5bxnI-2fhgH:
24.0		 5bxnH-2fhgH:
26.77
5bxnI-2fhgH:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fhg PROTEASOME, BETA
SUBUNIT

(Mycobacterium
tuberculosis) 		no annotation 8 THR H 301
SER H 320
GLN H 322
LYS H 333
ALA H 346
GLY H 347
THR H 348
ALA H 349
 None
 0.47A 5bxnH-2fhgH:
25.2
5bxnI-2fhgH:
24.0		 5bxnH-2fhgH:
26.77
5bxnI-2fhgH:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jz4 JASMONATE INDUCIBLE
PROTEIN ISOLOG

(Arabidopsis
thaliana) 		PF01419
(Jacalin) 		5 ALA A 263
GLY A 264
THR A 265
ALA A 266
THR A 232
 None
 0.89A 5bxnH-2jz4A:
undetectable
5bxnI-2jz4A:
undetectable		 5bxnH-2jz4A:
22.64
5bxnI-2jz4A:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rcs IMMUNOGLOBULIN 48G7
GERMLINE FAB

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.94A 5bxnH-2rcsH:
undetectable
5bxnI-2rcsH:
undetectable		 5bxnH-2rcsH:
21.84
5bxnI-2rcsH:
23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rkv TRICHOTHECENE
3-O-ACETYLTRANSFERAS
E

(Fusarium
graminearum) 		PF02458
(Transferase) 		5 GLN A 211
ALA A 218
GLY A 219
ALA A 369
CYH A 290
 None
 1.10A 5bxnH-2rkvA:
undetectable
5bxnI-2rkvA:
undetectable		 5bxnH-2rkvA:
20.53
5bxnI-2rkvA:
17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xa8 OMALIZUMAB HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 196
GLY H 142
THR H 143
ALA H 144
THR H 139
 None
 1.02A 5bxnH-2xa8H:
undetectable
5bxnI-2xa8H:
undetectable		 5bxnH-2xa8H:
23.05
5bxnI-2xa8H:
21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xtj FAB FROM A HUMAN
MONOCLONAL ANTIBODY,
1D05

(Homo sapiens) 		PF07654
(C1-set) 		5 SER E 206
GLY E 152
THR E 153
ALA E 154
THR E 149
 None
 0.93A 5bxnH-2xtjE:
undetectable
5bxnI-2xtjE:
undetectable		 5bxnH-2xtjE:
21.88
5bxnI-2xtjE:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z5x AMINE OXIDASE
[FLAVIN-CONTAINING]
A

(Homo sapiens) 		PF01593
(Amino_oxidase) 		5 ALA A 433
GLY A 434
THR A 435
ALA A 438
THR A 437
 None
FAD  A 600 (-3.1A)
FAD  A 600 (-3.4A)
None
None
 0.95A 5bxnH-2z5xA:
undetectable
5bxnI-2z5xA:
undetectable		 5bxnH-2z5xA:
18.93
5bxnI-2z5xA:
15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3alr NANOS PROTEIN

(Danio rerio) 		PF05741
(zf-nanos) 		5 ALA A 135
GLY A 134
THR A 133
ALA A 132
CYH A 130
 None
None
None
ZN  A 602 ( 4.7A)
ZN  A 602 (-2.3A)
 1.15A 5bxnH-3alrA:
undetectable
5bxnI-3alrA:
undetectable		 5bxnH-3alrA:
19.30
5bxnI-3alrA:
15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d85 FAB OF ANTIBODY
7G10, HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER B 190
GLY B 136
THR B 137
ALA B 138
THR B 133
 None
 0.80A 5bxnH-3d85B:
undetectable
5bxnI-3d85B:
undetectable		 5bxnH-3d85B:
22.01
5bxnI-3d85B:
23.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eqa GLUCOAMYLASE

(Aspergillus
niger) 		PF00723
(Glyco_hydro_15) 		5 THR A 176
GLN A 164
GLY A 231
THR A 228
ALA A 227
 None
 1.17A 5bxnH-3eqaA:
undetectable
5bxnI-3eqaA:
undetectable		 5bxnH-3eqaA:
19.57
5bxnI-3eqaA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g5s METHYLENETETRAHYDROF
OLATE--TRNA-(URACIL-
5-)-METHYLTRANSFERAS
E TRMFO

(Thermus
thermophilus) 		PF01134
(GIDA) 		5 THR A  19
SER A  76
GLY A 350
THR A 349
ALA A 348
 None
 1.22A 5bxnH-3g5sA:
undetectable
5bxnI-3g5sA:
undetectable		 5bxnH-3g5sA:
19.73
5bxnI-3g5sA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h0t FAB FRAGMENT, HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER B 197
GLY B 143
THR B 144
ALA B 145
THR B 140
 None
 0.90A 5bxnH-3h0tB:
undetectable
5bxnI-3h0tB:
undetectable		 5bxnH-3h0tB:
22.01
5bxnI-3h0tB:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i9g SONEPCIZUMAB
ANTIBODY FAB
FRAGMENT, HEAVY
CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.88A 5bxnH-3i9gH:
undetectable
5bxnI-3i9gH:
undetectable		 5bxnH-3i9gH:
20.55
5bxnI-3i9gH:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iu3 HEAVY CHAIN OF FAB
FRAGMENT OF
BASILIXIMAB

(Homo sapiens;
Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER A 190
GLY A 136
THR A 137
ALA A 138
THR A 133
 None
 0.97A 5bxnH-3iu3A:
undetectable
5bxnI-3iu3A:
undetectable		 5bxnH-3iu3A:
20.90
5bxnI-3iu3A:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ktd PREPHENATE
DEHYDROGENASE

(Corynebacterium
glutamicum) 		PF02153
(PDH) 		5 SER A 101
ALA A 126
GLY A 127
THR A 128
ALA A 129
 None
 0.87A 5bxnH-3ktdA:
undetectable
5bxnI-3ktdA:
undetectable		 5bxnH-3ktdA:
23.96
5bxnI-3ktdA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l7f H2L6 HEAVY CHAIN

(Homo sapiens) 		no annotation 5 SER H 196
GLY H 142
THR H 143
ALA H 144
THR H 139
 None
 0.88A 5bxnH-3l7fH:
undetectable
5bxnI-3l7fH:
undetectable		 5bxnH-3l7fH:
20.16
5bxnI-3l7fH:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mg6 PROTEASOME COMPONENT
PRE3

(Saccharomyces
cerevisiae) 		no annotation 5 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.57A 5bxnH-3mg6N:
29.5
5bxnI-3mg6N:
27.6		 5bxnH-3mg6N:
29.49
5bxnI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mlw HUMAN MONOCLONAL
ANTI-HIV-1 GP120 V3
ANTIBODY 1006-15D
FAB HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.98A 5bxnH-3mlwH:
undetectable
5bxnI-3mlwH:
undetectable		 5bxnH-3mlwH:
22.49
5bxnI-3mlwH:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oaz FAB 2G12, HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.91A 5bxnH-3oazH:
undetectable
5bxnI-3oazH:
undetectable		 5bxnH-3oazH:
19.43
5bxnI-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qhf HUMAN MONOCLONAL
ANTIBODY DEL2D1,
FAB HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.98A 5bxnH-3qhfH:
undetectable
5bxnI-3qhfH:
undetectable		 5bxnH-3qhfH:
20.95
5bxnI-3qhfH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qo0 FAB FRAGMENT OF
IMMUNOGLOBULIN G1
HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER B 194
GLY B 140
THR B 141
ALA B 142
THR B 137
 None
 0.89A 5bxnH-3qo0B:
undetectable
5bxnI-3qo0B:
undetectable		 5bxnH-3qo0B:
20.90
5bxnI-3qo0B:
22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qpx FAB C2507 HEAVY
CHAIN

(Homo sapiens;
Rattus
norvegicus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 194
GLY H 140
THR H 141
ALA H 142
THR H 137
 None
 0.81A 5bxnH-3qpxH:
undetectable
5bxnI-3qpxH:
undetectable		 5bxnH-3qpxH:
20.90
5bxnI-3qpxH:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u1s FAB PGT145 HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
 None
 0.87A 5bxnH-3u1sH:
undetectable
5bxnI-3u1sH:
undetectable		 5bxnH-3u1sH:
23.55
5bxnI-3u1sH:
23.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3unf PROTEASOME SUBUNIT
BETA TYPE-10

(Mus musculus) 		PF00227
(Proteasome)
PF12465
(Pr_beta_C) 		6 THR H   1
LYS H  33
ALA H  46
GLY H  47
ALA H  49
THR H  52
 04C  H 301 (-2.5A)
04C  H 301 (-3.5A)
04C  H 301 ( 4.3A)
04C  H 301 (-3.7A)
04C  H 301 (-3.6A)
04C  H 301 (-3.8A)
 0.44A 5bxnH-3unfH:
35.3
5bxnI-3unfH:
28.7		 5bxnH-3unfH:
46.35
5bxnI-3unfH:
23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v76 FLAVOPROTEIN

(Sinorhizobium
meliloti) 		PF03486
(HI0933_like) 		5 THR A 131
ALA A 149
GLY A 150
THR A 151
ASP A 153
 None
 1.18A 5bxnH-3v76A:
undetectable
5bxnI-3v76A:
undetectable		 5bxnH-3v76A:
21.12
5bxnI-3v76A:
19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wxr PROTEASOME SUBUNIT
BETA TYPE-5

(Saccharomyces
cerevisiae) 		PF00227
(Proteasome) 		5 THR L   1
LYS L  33
ALA L  46
GLY L  47
ALA L  49
 None
 0.44A 5bxnH-3wxrL:
28.7
5bxnI-3wxrL:
25.5		 5bxnH-3wxrL:
28.87
5bxnI-3wxrL:
22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zyx AMINE OXIDASE
[FLAVIN-CONTAINING]
B

(Homo sapiens) 		PF01593
(Amino_oxidase) 		5 ALA A 424
GLY A 425
THR A 426
ALA A 429
THR A 428
 None
FAD  A 600 (-3.3A)
FAD  A 600 (-3.4A)
None
None
 0.98A 5bxnH-3zyxA:
undetectable
5bxnI-3zyxA:
undetectable		 5bxnH-3zyxA:
17.68
5bxnI-3zyxA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f33 MORAB-009 FAB HEAVY
CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER B 194
GLY B 140
THR B 141
ALA B 142
THR B 137
 None
 0.78A 5bxnH-4f33B:
undetectable
5bxnI-4f33B:
undetectable		 5bxnH-4f33B:
21.03
5bxnI-4f33B:
23.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4glr ANTI-PTAU HEAVY
CHAIN

(Gallus gallus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.77A 5bxnH-4glrH:
undetectable
5bxnI-4glrH:
undetectable		 5bxnH-4glrH:
23.72
5bxnI-4glrH:
24.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h0m C-PHYCOCYANIN ALPHA
CHAIN
C-PHYCOCYANIN BETA
CHAIN

(Synechococcus
elongatus) 		PF00502
(Phycobilisome) 		5 THR B   6
GLN A  33
GLY A 105
THR A 104
ALA A  98
 None
 1.18A 5bxnH-4h0mB:
undetectable
5bxnI-4h0mB:
undetectable		 5bxnH-4h0mB:
22.09
5bxnI-4h0mB:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hfu FAB 8M2 HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.94A 5bxnH-4hfuH:
undetectable
5bxnI-4hfuH:
undetectable		 5bxnH-4hfuH:
22.52
5bxnI-4hfuH:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i3r HEAVY CHAIN OF
VRC-PG04 FAB

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 1.00A 5bxnH-4i3rH:
undetectable
5bxnI-4i3rH:
undetectable		 5bxnH-4i3rH:
21.80
5bxnI-4i3rH:
22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ke4 HYDROXYCINNAMOYL-COA
:SHIKIMATE
HYDROXYCINNAMOYL
TRANSFERASE

(Sorghum bicolor) 		PF02458
(Transferase) 		5 ALA A 289
GLY A 328
THR A 329
ALA A 332
THR A 331
 None
 1.23A 5bxnH-4ke4A:
undetectable
5bxnI-4ke4A:
undetectable		 5bxnH-4ke4A:
21.95
5bxnI-4ke4A:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ldq METHYLTHIORIBOSE-1-P
HOSPHATE ISOMERASE

(Homo sapiens) 		PF01008
(IF-2B) 		5 ALA A 172
GLY A 171
THR A 170
ALA A 174
THR A 175
 None
 1.20A 5bxnH-4ldqA:
undetectable
5bxnI-4ldqA:
undetectable		 5bxnH-4ldqA:
19.73
5bxnI-4ldqA:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mh1 SORBOSE
DEHYDROGENASE

(Ketogulonicigenium
vulgare) 		PF13360
(PQQ_2) 		5 SER A 152
ALA A 217
GLY A 216
THR A 215
THR A 235
 None
 1.14A 5bxnH-4mh1A:
undetectable
5bxnI-4mh1A:
undetectable		 5bxnH-4mh1A:
19.34
5bxnI-4mh1A:
16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oaw HEAVY CHAIN OF FAB
FRAGMENT OF
ANTI-HIV1 GP120 V2
MAB 2158

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER B 205
GLY B 151
THR B 152
ALA B 153
THR B 148
 None
 0.91A 5bxnH-4oawB:
undetectable
5bxnI-4oawB:
undetectable		 5bxnH-4oawB:
22.85
5bxnI-4oawB:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ocw CAP256-VRC26.06
HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 5bxnH-4ocwH:
undetectable
5bxnI-4ocwH:
undetectable		 5bxnH-4ocwH:
22.34
5bxnI-4ocwH:
23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4od1 CAP256-VRC26.03
HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.90A 5bxnH-4od1H:
undetectable
5bxnI-4od1H:
undetectable		 5bxnH-4od1H:
22.18
5bxnI-4od1H:
25.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qme AMINOPEPTIDASE N

(Neisseria
meningitidis) 		PF01433
(Peptidase_M1)
PF11940
(DUF3458)
PF17432
(DUF3458_C) 		5 THR A 466
ALA A 439
GLY A 440
THR A 441
ASP A 622
 None
 1.24A 5bxnH-4qmeA:
undetectable
5bxnI-4qmeA:
undetectable		 5bxnH-4qmeA:
14.50
5bxnI-4qmeA:
12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qv9 PROTEASOME SUBUNIT
BETA TYPE-5

(Saccharomyces
cerevisiae) 		PF00227
(Proteasome) 		5 THR K   1
LYS K  33
ALA K  46
GLY K  47
ALA K  49
 None
 0.35A 5bxnH-4qv9K:
28.9
5bxnI-4qv9K:
25.7		 5bxnH-4qv9K:
28.87
5bxnI-4qv9K:
27.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r4f ANTIBODY 2.2C HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 1.05A 5bxnH-4r4fH:
undetectable
5bxnI-4r4fH:
undetectable		 5bxnH-4r4fH:
20.65
5bxnI-4r4fH:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wgk NEUTRAL CERAMIDASE

(Homo sapiens) 		PF04734
(Ceramidase_alk)
PF17048
(Ceramidse_alk_C) 		5 SER A 164
GLN A 204
ALA A 200
GLY A 201
THR A 219
 None
 1.10A 5bxnH-4wgkA:
undetectable
5bxnI-4wgkA:
undetectable		 5bxnH-4wgkA:
16.18
5bxnI-4wgkA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xvs VRC07_1995
45-VRC01.H01+07.O-86
3513/45-VRC01.L01+07
.O-110653 HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 200
GLY H 146
THR H 147
ALA H 148
THR H 143
 None
 0.89A 5bxnH-4xvsH:
undetectable
5bxnI-4xvsH:
undetectable		 5bxnH-4xvsH:
22.39
5bxnI-4xvsH:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yaq PG9_N100FY FAB HEAVY
CHAIN

(Homo sapiens) 		no annotation 5 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 1.01A 5bxnH-4yaqH:
undetectable
5bxnI-4yaqH:
undetectable		 5bxnH-4yaqH:
20.60
5bxnI-4yaqH:
22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ye4 HEAVY CHAIN HUMAN
ANTIBODY HJ16

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 202
GLY H 148
THR H 149
ALA H 150
THR H 145
 None
 0.78A 5bxnH-4ye4H:
undetectable
5bxnI-4ye4H:
undetectable		 5bxnH-4ye4H:
24.22
5bxnI-4ye4H:
23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a5t EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT F

(Oryctolagus
cuniculus) 		PF01398
(JAB)
PF13012
(MitMem_reg) 		5 THR F 200
GLY F 196
THR F 195
ALA F 194
THR F 221
 None
 1.13A 5bxnH-5a5tF:
undetectable
5bxnI-5a5tF:
undetectable		 5bxnH-5a5tF:
20.33
5bxnI-5a5tF:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cd3 DRVIA7 HEAVY CHAIN

(Homo sapiens) 		no annotation 5 SER G 187
GLY G 133
THR G 134
ALA G 135
THR G 130
 None
 0.88A 5bxnH-5cd3G:
undetectable
5bxnI-5cd3G:
undetectable		 5bxnH-5cd3G:
19.26
5bxnI-5cd3G:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dmh UNCHARACTERIZED
PROTEIN CONSERVED IN
BACTERIA

(Cupriavidus
necator) 		PF07005
(DUF1537)
PF17042
(DUF1357_C) 		5 THR A 277
LYS A 412
ALA A 270
GLY A 271
THR A 373
 None
None
None
ADP  A 501 (-3.6A)
ADP  A 501 (-3.8A)
 1.21A 5bxnH-5dmhA:
undetectable
5bxnI-5dmhA:
undetectable		 5bxnH-5dmhA:
22.27
5bxnI-5dmhA:
18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f89 CAP248-2B HEAVY
CHAIN

(Homo sapiens) 		no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.86A 5bxnH-5f89H:
undetectable
5bxnI-5f89H:
undetectable		 5bxnH-5f89H:
20.37
5bxnI-5f89H:
22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fg9 PROTEASOME SUBUNIT
BETA TYPE-2

(Saccharomyces
cerevisiae) 		PF00227
(Proteasome)
PF12465
(Pr_beta_C) 		9 THR H   1
SER H  20
GLN H  22
LYS H  33
ALA H  46
GLY H  47
THR H  48
ALA H  49
THR H  52
 None
 0.64A 5bxnH-5fg9H:
35.9
5bxnI-5fg9H:
26.2		 5bxnH-5fg9H:
97.88
5bxnI-5fg9H:
23.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fmg BETA3 PROTEASOME
SUBUNIT, PUTATIVE
PROTEASOME SUBUNIT
BETA TYPE

(Plasmodium
falciparum) 		PF00227
(Proteasome) 		6 THR I   1
LYS I  33
ALA I  46
GLY I  47
ALA I  49
ASP J 138
 7F1  I 300 (-2.7A)
7F1  I 300 (-4.7A)
None
7F1  I 300 (-3.8A)
7F1  I 300 (-3.5A)
7F1  I 300 (-2.6A)
 1.09A 5bxnH-5fmgI:
30.1
5bxnI-5fmgI:
26.7		 5bxnH-5fmgI:
48.51
5bxnI-5fmgI:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g4g VCP-LIKE ATPASE

(Thermoplasma
acidophilum) 		PF00004
(AAA)
PF02359
(CDC48_N)
PF02933
(CDC48_2) 		5 GLN A 108
ALA A 143
GLY A 144
THR A 146
ASP A 107
 None
 1.11A 5bxnH-5g4gA:
undetectable
5bxnI-5g4gA:
undetectable		 5bxnH-5g4gA:
15.51
5bxnI-5g4gA:
15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i2h O-METHYLTRANSFERASE
FAMILY 2

(Planctopirus
limnophila) 		PF00891
(Methyltransf_2)
PF16864
(Dimerisation2) 		5 SER A 328
ALA A 312
GLY A 307
THR A 306
THR A  69
 None
 1.21A 5bxnH-5i2hA:
undetectable
5bxnI-5i2hA:
undetectable		 5bxnH-5i2hA:
21.70
5bxnI-5i2hA:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i8k HHH1 FAB HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 191
GLY H 137
THR H 138
ALA H 139
THR H 134
 None
 0.91A 5bxnH-5i8kH:
undetectable
5bxnI-5i8kH:
undetectable		 5bxnH-5i8kH:
20.39
5bxnI-5i8kH:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jp6 PUTATIVE
POLYSACCHARIDE
DEACETYLASE

(Bdellovibrio
bacteriovorus) 		PF01522
(Polysacc_deac_1) 		5 ALA A 264
GLY A 204
THR A 203
ALA A 202
ASP A 336
 None
 1.21A 5bxnH-5jp6A:
undetectable
5bxnI-5jp6A:
undetectable		 5bxnH-5jp6A:
23.31
5bxnI-5jp6A:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kan 16.G.07 HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER G 203
GLY G 149
THR G 150
ALA G 151
THR G 146
 None
 1.17A 5bxnH-5kanG:
undetectable
5bxnI-5kanG:
undetectable		 5bxnH-5kanG:
21.15
5bxnI-5kanG:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l5w PROTEASOME SUBUNIT
BETA
TYPE-5,PROTEASOME
SUBUNIT BETA TYPE-5

(Homo sapiens;
Saccharomyces
cerevisiae) 		PF00227
(Proteasome) 		5 THR K   1
LYS K  33
ALA K  46
GLY K  47
ALA K  49
 None
 0.43A 5bxnH-5l5wK:
29.0
5bxnI-5l5wK:
25.5		 5bxnH-5l5wK:
29.18
5bxnI-5l5wK:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5loy DESIGNED ANBU
PROTEIN

(synthetic
construct) 		PF00227
(Proteasome) 		5 THR A   1
LYS A  32
ALA A  49
GLY A  50
THR A  55
 None
 0.83A 5bxnH-5loyA:
4.6
5bxnI-5loyA:
20.9		 5bxnH-5loyA:
22.75
5bxnI-5loyA:
29.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4g HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 190
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.85A 5bxnH-5n4gH:
undetectable
5bxnI-5n4gH:
undetectable		 5bxnH-5n4gH:
23.64
5bxnI-5n4gH:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nyx HEAVY CHAIN

(Homo sapiens) 		no annotation 5 SER H 198
GLY H 144
THR H 145
ALA H 146
THR H 141
 None
 0.85A 5bxnH-5nyxH:
undetectable
5bxnI-5nyxH:
undetectable		 5bxnH-5nyxH:
16.59
5bxnI-5nyxH:
15.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t0h PROTEASOME SUBUNIT
BETA TYPE-7

(Homo sapiens) 		PF00227
(Proteasome)
PF12465
(Pr_beta_C) 		7 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.94A 5bxnH-5t0hO:
29.6
5bxnI-5t0hO:
26.3		 5bxnH-5t0hO:
55.74
5bxnI-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t3x IOMA HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER D 188
GLY D 134
THR D 135
ALA D 136
THR D 131
 None
 1.13A 5bxnH-5t3xD:
undetectable
5bxnI-5t3xD:
undetectable		 5bxnH-5t3xD:
20.93
5bxnI-5t3xD:
22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5trp DH272 FAB HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 197
GLY H 143
THR H 144
ALA H 145
THR H 140
 None
 0.93A 5bxnH-5trpH:
undetectable
5bxnI-5trpH:
undetectable		 5bxnH-5trpH:
23.47
5bxnI-5trpH:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tvg ALPHA,ALPHA-TREHALOS
E-PHOSPHATE SYNTHASE
(UDP-FORMING)

(Burkholderia
vietnamiensis) 		PF00982
(Glyco_transf_20) 		5 SER A 196
ALA A 215
GLY A 205
THR A 206
ALA A 207
 None
 1.17A 5bxnH-5tvgA:
undetectable
5bxnI-5tvgA:
undetectable		 5bxnH-5tvgA:
20.75
5bxnI-5tvgA:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u3j DH511.1 HEAVY CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 5bxnH-5u3jH:
undetectable
5bxnI-5u3jH:
undetectable		 5bxnH-5u3jH:
22.63
5bxnI-5u3jH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u3n DH511.12P FAB HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 5bxnH-5u3nH:
undetectable
5bxnI-5u3nH:
undetectable		 5bxnH-5u3nH:
23.08
5bxnI-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uem 354NC37 FAB HEAVY
CHAIN

(Homo sapiens) 		no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.93A 5bxnH-5uemH:
undetectable
5bxnI-5uemH:
undetectable		 5bxnH-5uemH:
16.81
5bxnI-5uemH:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w1k CR1-10 FAB HEAVY
CHAIN

(Homo sapiens) 		no annotation 5 SER D 201
GLY D 147
THR D 148
ALA D 149
THR D 144
 None
 0.86A 5bxnH-5w1kD:
undetectable
5bxnI-5w1kD:
undetectable		 5bxnH-5w1kD:
15.19
5bxnI-5w1kD:
16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wcc VRC 315 02-1F07 FAB
HEAVY CHAIN

(Homo sapiens) 		no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.85A 5bxnH-5wccH:
undetectable
5bxnI-5wccH:
undetectable		 5bxnH-5wccH:
16.90
5bxnI-5wccH:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wl2 -

(-) 		no annotation 5 SER H 196
GLY H 142
THR H 143
ALA H 144
THR H 139
 None
 0.89A 5bxnH-5wl2H:
undetectable
5bxnI-5wl2H:
undetectable		 5bxnH-5wl2H:
undetectable
5bxnI-5wl2H:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wna MAB 3D3 FAB HEAVY
CHAIN

(Homo sapiens) 		no annotation 5 SER H 199
GLY H 145
THR H 146
ALA H 147
THR H 142
 None
 0.83A 5bxnH-5wnaH:
undetectable
5bxnI-5wnaH:
undetectable		 5bxnH-5wnaH:
16.37
5bxnI-5wnaH:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x5x FD CHAIN OF
ANTI-OSTEOCALCIN
ANTIBODY KTM219

(Mus musculus) 		no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.73A 5bxnH-5x5xH:
undetectable
5bxnI-5x5xH:
undetectable		 5bxnH-5x5xH:
15.09
5bxnI-5x5xH:
19.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6avo PROTEASOME SUBUNIT
BETA TYPE-10

(Homo sapiens) 		no annotation 5 THR B   1
LYS B  33
ALA B  46
GLY B  47
ALA B  49
 None
 0.69A 5bxnH-6avoB:
21.1
5bxnI-6avoB:
18.1		 5bxnH-6avoB:
43.40
5bxnI-6avoB:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b5n CIS43 FAB HEAVY
CHAIN

(Homo sapiens) 		no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 1.02A 5bxnH-6b5nH:
undetectable
5bxnI-6b5nH:
undetectable		 5bxnH-6b5nH:
22.50
5bxnI-6b5nH:
16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bf4 VRC-PG05 FAB HEAVY
CHAIN

(Homo sapiens) 		no annotation 5 SER B 188
GLY B 134
THR B 135
ALA B 136
THR B 131
 None
 1.08A 5bxnH-6bf4B:
undetectable
5bxnI-6bf4B:
undetectable		 5bxnH-6bf4B:
16.67
5bxnI-6bf4B:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cdm VFP7.04 HEAVY CHAIN

(Mus musculus) 		no annotation 5 SER A 188
GLY A 134
THR A 135
ALA A 136
THR A 131
 None
 0.99A 5bxnH-6cdmA:
undetectable
5bxnI-6cdmA:
undetectable		 5bxnH-6cdmA:
18.78
5bxnI-6cdmA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6db6 HUMAN MONOCLONAL
ANTI-HIV-1 GP120 V3
ANTIBODY 311-11D FAB
HEAVY CHAIN

(Homo sapiens) 		no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.97A 5bxnH-6db6H:
undetectable
5bxnI-6db6H:
undetectable		 5bxnH-6db6H:
14.36
5bxnI-6db6H:
17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6db7 HUMAN MONOCLONAL
ANTI-HIV-1 GP120 V3
ANTIBODY 1334 FAB
HEAVY CHAIN

(Homo sapiens) 		no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 GOL  H 301 (-4.2A)
GOL  H 303 (-3.2A)
None
None
None
 0.90A 5bxnH-6db7H:
undetectable
5bxnI-6db7H:
undetectable		 5bxnH-6db7H:
15.66
5bxnI-6db7H:
17.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6elj FAB HEAVY CHAIN

(Homo sapiens) 		no annotation 5 SER A 199
GLY A 145
THR A 146
ALA A 147
THR A 142
 None
 0.81A 5bxnH-6eljA:
undetectable
5bxnI-6eljA:
undetectable		 5bxnH-6eljA:
21.65
5bxnI-6eljA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6frv GLUCOAMYLASE

(Aspergillus
niger) 		no annotation 5 THR A 176
GLN A 164
GLY A 231
THR A 228
ALA A 227
 None
 1.21A 5bxnH-6frvA:
undetectable
5bxnI-6frvA:
undetectable		 5bxnH-6frvA:
15.98
5bxnI-6frvA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gk7 HUMAN FAB ANTIBODY
FRAGMENT OF
CBTAU-27.1(S31Y,T100
I)

(Homo sapiens) 		no annotation 5 SER H 197
GLY H 143
THR H 144
ALA H 145
THR H 140
 None
 0.94A 5bxnH-6gk7H:
undetectable
5bxnI-6gk7H:
undetectable		 5bxnH-6gk7H:
15.90
5bxnI-6gk7H:
21.02